Biocon's Kiran Mazumdar-Shaw suggests a new drug approval system. The Indian Council of Medical Research would handle scientific reviews fo...

The World Health Organisation has issued a global alert for three Indian cough syrups. These syrups were found to be substandard and contai...

DCGI Dr. Rajeev Raghuvanshi highlighted India's leading role in global adverse event reporting during the 5th National Pharmacovigilance We...

Beta-blockers, used for irregular heartbeat and hypertension, can cause dangerously low potassium levels, known as hypokalaemia, according ...

Novo Nordisk's India team played a pivotal role in the success of Ozempic, a semaglutide-based drug for diabetes and weight management. The...

The new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthe...

In the next five years, drug patents with sales worth $170 billion will expire globally, driving demand for cost-effective generic drugs. A...

The EMA is the regulator for all human and animal medicines in the 27 nations of the European Union plus the European Economic Area countri...

he way the global scientific community has come together to focus on ensuring affordable access to new vaccines and therapies for humanity ...

The main areas of cooperation between the two regulatory authorities include exchange of safety information, including pharmacovigilance wh...

In return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...

Some major projects of the Ministry of Ayush have failed to take off since its inception due to "non-availability of land" and surrendered ...

Officials say the new norms will be finalised after consultations with the industry, academic institutions and stakeholders like the civil ...

"There are variations in each individual in conversions of codeine to morphine and each individual reacts differently," Prof K C Singhal.

Under terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck.

The clinical research division at Fortis Healthcare, also plans to hire more medical professionals next year.

Assocham has said it expects the Indian pharmaceutical industry to reach $20 billion by 2015, making it one of the world's top 10 pharmaceu...